Clinical Data from Phase 2 Studies in Total Knee Arthroplasty (TKA) and Bunionectomy to be Presented…
Autor: Press Room
35 years of experience in the field of communications specialized in various business areas, such as administration, marketing, writing, public relations and more.
Goehring & Rozencwajg Launches UK Feeder Fund to Tap into Commodity Market Growth
The CG Goehring & Rozencwajg Resources Feeder Fund will be available to UK retail investors NEW…
e.l.f. Cosmetics and World Champion Blind Swimmer Anastasia Pagonis Launch “Beauty For Every Eye” Accessibility Bundle
New limited edition product bundle has an accessibility feature created by the blind world champion. OAKLAND,…
W.P. Carey Inc. (WPC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK–(BUSINESS WIRE)–$WPC #classaction–Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of…
Singapore’s National Precision Medicine (NPM) Programme Engages Oxford Nanopore to Advance Understanding of the Genetics of Singapore’s Multi-Ethnic Population
Singapore’s National Precision Medicine (NPM) programme will sequence 10,000 genomes to improve understanding of genetic architecture…
TSLA Investors Have Opportunity to Join Tesla, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is…
DXC Investors Have Opportunity to Lead DXC Technology Company Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a…
Triple-I Offers Floridians, Southeast U.S. Residents Preparedness Tips for Impacts of Tropical Storm Debby
ST. JOHNS, Fla.–(BUSINESS WIRE)–Residents of Florida and the Southeast should be alert for the potential impacts…
RIBOMIC Announces Completion of Patient Enrollment in Early Phase II Study of umedaptanib pegol for Achondroplasia and Initiation of Dosing in Cohort 2 of Early Phase II Clinical Study
TOKYO–(BUSINESS WIRE)–RIBOMIC Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, today announced that 13…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Five Below, Inc. (FIVE) Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces…